Treatment of low-risk gestational trophoblastic neoplasia
- PMID: 21263092
- DOI: 10.1200/JCO.2010.31.0151
Treatment of low-risk gestational trophoblastic neoplasia
Comment on
-
Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.J Clin Oncol. 2011 Mar 1;29(7):825-31. doi: 10.1200/JCO.2010.30.4386. Epub 2011 Jan 24. J Clin Oncol. 2011. PMID: 21263100 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
